Displaying 26–50 of 630 results for Pharmaceutical Manufacturing staff

Sort By Relevance Sort By Date
1 2 3 4 5 ...26

2018 Pharma Innovation Awards

(Article)

A much-deserved celebration of manufacturing technologies, hand-picked by Pharmaceutical Manufacturing

Innovation Gets Regulatory Backing

(Article)

The FDA is working to facilitate the uptake of emerging manufacturing technologies

API Sourcing: Your Questions Answered

(Article)

Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains

Grand River Aseptic Manufacturing expands capacity

(News)

The Bausch+Ströbel filler can fill 200 vials per minute and will more than triple GRAM’s manufacturing capacity.

The Digital Pharma Factory of Tomorrow

(Article)

Pharma companies that embrace a digital factory approach will see improvements in data availability, visibility and decision-making

Digital Transformation can Flip the 80/20 Rule Around

(Article)

Data from a range of sources can be an enormous asset to discovery initiatives, generating new insights and enabling pharma companies to track progress at the granular level.

Cutting-Edge Flexibility

(Article)

CDMOs perfect the art of survival in today’s multi-product world

EU FMD: The One-Year Countdown

(Article)

Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply – where does the industry stand?

Creating a Successful Maintenance Strategy for Pharma Plants

(Article)

Creating a Successful Maintenance Strategy for Pharma Plants

Federal Equipment adds new equipment, classroom capacity and training courses

(News)

"The Manufacturing Process" is a comprehensive solid dose training course offering practical information on how tablets and capsules are made. Participants will be able identify machinery, why it is used, and what it does

Regulatory Intelligence Brief: 2017 FDA Overview

(Article)

All the major changes this year including guidance documents drafted and finalized, new legislation, other areas of interest and some tools to help you explore additional areas not covered herein but might be of interest to you; the impact of these changes is provided for some of the information.

Leveraging Platform Analytical Methods for Biopharma QbD

(Article)

How To Leveraging Platform Analytical Methods for Biopharma QbD

Industrial Cybersecurity Defenses Essential for Pharma Companies

(Article)

Pharma manufacturers need to be on the alert to get their IT security and Industrial Control Systems security readied to protect assets and industrial processes

Biopharma Benchmarking Unveils Performance Variance

(Article)

Performance gaps suggest that it’s time for biopharma manufacturing companies to focus on operational excellence

Henry Ford Had It Right

(Article)

Hand-made to assembly lines, now, to automated production

FDA Makes Historic Approval of Novartis Gene Therapy

(News)

The U.S. FDA approved the first cell-based gene therapy, known as Kymriah, for young adult patients with a form of acute lymphoblastic leukemia.

Pharma’s Untapped Gold Mine: Logistics Excellence

(Article)

Accurate, timely logistics performance is essential for pharma companies, but sometimes it can be taken for granted and end up costing you more down the road.

All-Star Innovators 2017

(Article)

Pharma’s All-Star tech lineup shatters records with plenty of hits.

Market Research: Quality, Compliance and Risk Management

(Article)

New report analyzes survey results that point to an overall lack of confidence in current quality management systems

Making the Move

(Article)

A best practice approach to migrating to electronic batch records (EBRs) in pharmaceutical manufacturing requires MES technology

Q&A: 3D Technology Emerges

(Article)

With the FDA acknowledging 3D printing as an important emerging technology in the pharmaceutical industry, David Hess, Technical Solutions Consultant at Sparta Systems, explores the impact, benefits and risks of 3D drug printing

ET Phone Home, Then Call the FDA

(Article)

In FDA’s world, ET does not refer to The Extra-Terrestrial as made famous by the movie, but rather Emerging Technologies, and it set up a special task force to facilitate pharmaceutical innovation

Sort By Relevance Sort By Date
1 2 3 4 5 ...26